Molecular and cell biological aspects of Alzheimer disease

Journal of Human Genetics

Volumn 46, Issue 11, 2001, Pages 609-618

  Shastry, B S ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Amyloid; Gene; Mutation; Oxidative stress; Presenilins

Indexed keywords

AMYLOID BETA PROTEIN; DONEPEZIL; TACRINE;

ABDOMINAL PAIN; ALZHEIMER DISEASE; AUTOSOMAL DOMINANT DISORDER; CYTOLOGY; FAMILIAL DISEASE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNIZATION; LIVER TOXICITY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NAUSEA; PATHOPHYSIOLOGY; SHORT SURVEY; VOMITING;

ALZHEIMER DISEASE; GENES, DOMINANT; HUMANS; MOLECULAR BIOLOGY; MUTATION;

EID: 0035211507     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380170011     Document Type: Short Survey

References (183)

1. Association between an α 2 microglobulin DNA polymorphism and late-onset Alzheimer disease
2. Cerebrospinal fluid β-amyloid in Alzheimer disease
3. V717F transgenic mouse model of Alzheimer disease
4. Brain choline acetyltransferase and mental function in Alzheimer disease
5. Lipoprotein lipase mutation and Alzheimer disease
6. Alzheimer disease and oxidative stress: Implication for novel therapeutic approaches
7. Hydrogen peroxide mediates amyloid β protein toxicity
8. Impairment of the ubiquitin-proteasome system by protein aggregation
9. Evidence for genetic linkage of Alzheimer disease to chromosome 10q
10. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration
11. MRI of entorhinal cortex in mild Alzheimer disease
12. Patterns of brain activation in people at risk for Alzheimer disease
13. Alzheimer disease: Neurodevelopment converges with neurodegeneration
14. Association of the estrogen receptor α gene polymorphisms with sporadic Alzheimer disease
15. β-amyloid precursor protein mediates neuronal cell-cell and cell surface adhesion
16. Disruption of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias
17. Might olfactory dysfunction be a marker of early Alzheimer disease
18. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding
19. Calsenilin: A calcium binding protein that interacts with the presenilins and regulates the level of a presenilin fragment
20. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity and mutation spectrum
21. The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer brain
22. The multiple paradoxes of presenilins
23. A learning deficit related to age and β amyloid plaque in a mouse model of Alzheimer disease
24. Transgenic mice with Alzheimer presenilin-1 mutations show accelerated neurodegeneration without amyloid plaque formation
25. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late-onset families
26. Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigree
27. The number of trait loci in late-onset Alzheimer disease
28. Closing in on χ-secretase
29. Proteolytic processing and cell biological functions of the amyloid precursor protein
30. A firm base for drug development
31. Phosphorylation, subcellular localization and membrane orientation of the Alzheimer disease-associated presenilins
32. A presenilin-1 dependent χ-secretase-like protease mediates release of Notch intracellular domain
33. The Glu318Gly substitution in presenilin-1 is not causally related to Alzheimer disease
34. Specific binding of the β amyloid precursor protein to the presenilins induces extracellular signaling: Its significance for Alzheimer disease
35. Molecular basis of Alzheimer disease
36. Increased amyloid β 42 in brain of mice expressing mutant presenilin-1
37. Prevalence and types of dementia in the very old: Results from the Canadian study of health and aging
38. Alzheimer disease
39. Linkage of plasma Aβ 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer disease pedigree
40. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer disease
41. Association between angiotensin-converting enzyme and Alzheimer disease
42. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease
43. Acetyl cholinesterase inhibitors for Alzheimer disease
44. Diagnosis of early Alzheimer disease
45. Serial magnetic resonance imaging of cerebral atrophy in pre-clinical Alzheimer disease
46. A nucleated assembly mechanism of Alzheimer paired helical filaments
47. Increased nuclear DNA oxidation in the brain in Alzheimer disease
48. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β amyloid precursor protein
49. Apolipoprotein E polymorphism and Alzheimer disease
50. Segregation of a missense mutation in the amyloid precursor protein gene with familial AIzheimer disease
51. Pinning down phosphorylated tau
52. Genetics of neuroinflammation in Alzheimer disease
53. Histopathology and APOE genotype of the first Alzheimer patient Auguste D
54. Biomarkers of Alzheimer disease
55. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice
56. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS-1 mutation
57. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor
58. The presenilins in Alzheimer disease - Proteolysis holds the key
59. Effect of anti-inflammatory medications on neuropathological findings in Alzheimer disease
60. Presenilin-1 regulates neuronal differentiation during neurogenesis
61. Altered microtubule organization in small caliber axons of mice lacking tau protein
62. In search of χ-secretase
63. Genetic dissection of Alzheimer disease and related dementias
64. Neurofibrillary tangles in non-demented elderly subjects and mild Alzbeimer disease
65. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions
66. Incidence of dementia and Alzheimer diseases in two communities
67. Presenilin-2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin-1 deficiency
68. Linkage disequilibrium in the 13q12 region in Finnish late-onset Alzheimer disease patients
69. Region-specific neurotrophin imbalances in Alzheimer disease
70. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgene
71. Apolipoprotein E isoform dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer disease
72. Regeneration of the damaged central nervous system
73. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
74. Cu(II) potentiation of Alzheimer Aβ neurotoxicity
75. Metabolic regulation of brain Aβ by neprilysin
76. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer disease
77. Clinical and pathological evidence for a frontal variant of Alzheimer disease
78. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer disease in the Japanese population
79. The precursor of Alzheimer disease amyloid A4 protein resembles a cell surface receptor
80. Presenilin-1 mutations down regulate the signaling pathway of the unfolded protein response
81. A full genome scan for late-onset Alzheimer disease
82. No association between the genes for butylrylcholinesterase K variant and apolipoprotein ε 4 in late-onset Alzheimer disease
83. β-amyloid precursor protein binds to the neurite promoting IKVAV site of lamin
84. Ligand dependent tau filament formation: Implication for Alzheimer disease
85. Comparative analysis of amyloid β chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer disease brains
86. Neuronal cell death in Alzheimer disease correlates with APOE uptake and intracellular Aβ stabilization
87. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice
88. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer disease
89. Exploring the etiology of Alzheimer disease using molecular genetics
90. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia
91. Presenilin-1 is linked with χ-secretase activity in the detergent solubilized state
92. Mechanism of the cleavage specificity of Alzheimer disease χ-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein
93. Deposition of β-amyloid subtype 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease
94. Histidine-13 is a crucial residue in the zinc ion induced aggregation of the Aβ peptide of Alzheimer disease
95. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
96. Amyloid β interacts with amyloid precursor protein: A potential toxic mechanism in Alzheimer disease
97. The prolyl isomerase pin 1 restores the function of Alzheimer associated phosphorylated tau protein
98. Tau in Alzheimer disease
99. Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease
100. Alzheimer disease-linked mutation of presenilin-2 (N141I - PS2) drastically lowers APPα secretion: Control by the proteosome
101. The role of oxidative stress in Alzheimer disease
102. Lack of association of estrogen receptor α gene polymorphisms and transcriptional activity with Alzheimer disease
103. Cellular actions of β amyloid precursor protein and its soluble and fibrillogenic peptide derivatives
104. Treatment of Alzheimer disease
105. Plasma amyloid β-peptide 42 and incipient Alzheimer disease
106. Autotoxicity and Alzheimer disease
107. Risk of Alzheimer disease is associated with a very low density lipoprotein receptor genotype in Northern Ireland
108. Protection agaist β amyloid toxicity in primary neurons by paclitaxel (taxol)
109. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer disease
110. Is Alzheimer disease inevitable with age?
111. Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
112. Susceptibility locus for Alzheimer disease on chromosome 10
113. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
114. Alzheimer disease: A reexamination of the amyloid hypothesis
115. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex
116. A role for presenilin-1 in nuclear accumulation of Ire 1 fragments and induction of mammalian unfolded protein response
117. The role of presenilin-1 in the χ-secretase cleavage of the amyloid precursor protein of Alzheimer disease
118. Regulation of amyloid precursor protein processing by presenilin-1 (PS1) and PS2 in PS1 knock-out cells
119. Dementia with Lewy bodies: The second most common cause of dementia
120. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
121. A familial case of Alzheimer disease without tau pathology may be linked with chromosome 3 markers
122. Apolipoprotein E in animal models of central nervous system injury and in Alzheimer disease
123. Apolipoprotein E and cognitive performance
124. Functional brain imaging to identify affected subjects genetically at risk for Alzheimer disease
125. Cell surface presenilin-1 participates in the χ-secretase-like proteolysis of Notch
126. Familial Alzheimer disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer disease type 3 gene
127. Opposite roles of apolipoprotein E in normal brain and in Alzheimer disease
128. Presenilin-1 mutations in Alzheimer disease
129. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease
130. Association of apolipoprotein E allele ε 4 with late-onset familial and sporadic Alzheimer disease
131. Immunization with amyloid β attenuates Alzheimer disease-like pathology in the PDAPP mouse
132. Secreted amyloid β-protein similar to that in the senile plaque of Alzheimer disease is increased in vivo by the presenilins-1 and 2 and APP mutation linked to familial Alzheimer disease
133. Phosphorylation that detaches tau protein from microtubules also protects it against aggregation into Alzheimer paired helical filaments
134. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation
135. Further evidence linking late-onset Alzheimer disease with chromosome 12
136. The cell biology of β-amyloid precursor protein and presenilins in Alzheimer disease
137. Translating cell biology into therapeutic advances in Alzheimer disease
138. Alzheimer's disease: Genes, proteins and therapy
139. In search of χ-secretase: Presenilins at the cutting edge
140. Molecular genetics of familial Alzheimer disease
141. Genes and susceptible loci of Alzheimer disease
142. Cortical inflammation in Alzheimer disease but not dementia with Lewy body
143. Cloning of a novel gene bearing a missense mutation in early-onset familial Alzheimer disease
144. Cognitive loss in dementia with Lewy bodies and Alzheimer disease
145. Identifying families with likely genetic protective factors against Alzheimer disease
146. Alzheimer disease: Perspectives for the new millennium
147. An accomplice for χ-secretase brought into focus
148. Detection of pre-clinical Alzheimer disease
149. In vivo detection of amyloid plaques in a mouse model of Alzheimer disease
150. The role of presenilins in χ-secretase activity: Catalyst or cofactor?
151. No association between the HLA-A2 allele and Alzheimer disease
152. The course of cognitive impairment in pre-clinical Alzheimer disease
153. Regulation brain G-protein G0 by Alzheimer disease gene presenilin-1
154. A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling
155. Piecing together Alzheimer's
156. Presenilin is required for activity and nuclear access of Notch in Drosophila
157. Two amyloid precursor protein transgenic mice models with Alzheimer disease-like pathology
158. Presenilin-1 associates with glycogen synthase 3β and its substrate tau
159. Microglial activation resulting from CD40-CD40L interaction after β amyloid stimulation
160. Alzheimer disease associated presenilin-2 interacts with DRAL, an LIM-domain protein
161. A genetic dichotomy model for the inheritance of Alzheimer disease and common age related disorders
162. The role of presenilins in Alzheimer disease
163. Evaluation of polymorphisms in the presenilin-1 gene and the butylrylcholinesterase gene as a risk factor in sporadic Alzheimer disease
164. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series
165. Glutamine synthetase in cerebrospinal fluid, serum and brain
166. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer disease in a population based samples
167. Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer disease
168. Lack of association between α 2 microglobulin polymorphisms and Alzheimer disease
169. Association between coding variability in the LRP gene and the risk of late-onset Alzheimer disease
170. Presenilins and χ-secretase: Structure meets function
171. The role of presenilins in χ-secretase activity
172. Two transmembrane aspartates in presenilin-1 is required for presenilin endo-proteolysis and χ-secretase activity
173. Are presenilins intramembrane-cleaving proteases? Implication for the molecular mechanism of Alzheimer disease
174. Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro
175. Presenilin-1 regulates the processing of β amyloid precursor protein C-terminal fragment and the generation of the amyloid β protein in the endoplasmic reticulum and Golgi
176. Presenilin complexes with the C-terminal fragment of amyloid precursor protein at the site of amyloid β-protein generation
177. An intracellular protein that binds amyloid β peptide and mediates neurotoxicity in Alzheimer disease
178. A pedigree with a novel presenilin-1 mutation at a residue that is not conserved in presenilin-2
179. Neurogenic phenotype and altered Notch processing in Drosophila presenilin mutants
180. Interaction of presenilins with the filamin family of actin binding proteins
181. Destabilization of β-catenin by mutation in presenilin-1 potentiates neuronal apoptosis
182. Biochemical characterization of the χ-secretase activity that produces β amyloid peptides
183. Increased neurodegeneration during aging in mice lacking high affinity nicotine receptors